Skip to main content
Clinical Trials/CTRI/2025/01/079480
CTRI/2025/01/079480Not yet recruitingPhase 2

To see the efficacy of Durwadi Ghrit in the management of Dushta Vrana (infected wound)

Dr Kanak Lata Mishra1 site in 1 country60 target enrollmentStarted: February 10, 2025Last updated:

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Sponsor
Enrollment
60
Locations
1
Primary Endpoint
Finally the treatment will be assessed on assessment criteria of Dusta vrana Criteria for assessing clinical features

Study Overview

Brief Summary

The whole research work will be summarized  on the basis of the observation which will be done on the subjective and objective parameters.

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
None

Eligibility Criteria

Ages
18.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Post surgical wound infection
  • Traumatic infected wound
  • Diabetic wound
  • Infected wound.

Exclusion Criteria

  • • Malignant ulcer • Tubercular ulcer • Syphilitic ulcer • Leprotic ulcer • Actinomyecetes • HIV (+) patient’s wound • HBsAg(+) patients wound.

Outcomes

Primary Outcomes

Finally the treatment will be assessed on assessment criteria of Dusta vrana Criteria for assessing clinical features

Time Frame: 1 month

Score Pain Discharge Slough tissue

Time Frame: 1 month

0 No pain Nodischarge/dry dressing No slough tissue

Time Frame: 1 month

1 Localized feeling of pain during movement only but no feeling during rest Scanty occasional discharge & little wet dressing Up to 25% area covered with slough

Time Frame: 1 month

2 Localized feeling of pain even during rest but not disturbing the sleep Often discharge & with blood on dressing 26 to 50% area covered with slough

Time Frame: 1 month

3 Localized continuous feeling of pain, radiating & not relieved by rest Profuse, continuous discharge which needs frequent dressing More than 50% area covered with slough

Time Frame: 1 month

Secondary Outcomes

  • This includes mainly size measurements, photography, and tracing. These are performed on weekly basis to estimate baseline wound status, recovery size measurements, validate overall treatment plan and to demonstrate short term response to treatment plan(1 month)

Investigators

Sponsor
Dr Kanak Lata Mishra
Sponsor Class
Other [self]
Responsible Party
Principal Investigator
Principal Investigator

kanaklata misra

S. G. M. P. G. Ayurvedic college and hospital

Study Sites (1)

Loading locations...

Similar Trials